WEBSITECHANGES

Website Changes

---

01/25/2020

University Hospitals Seidman Cancer Center treats its first glioblastoma patient with genetically modified poliovirus

---

01/21/2020

Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling

---

01/21/2020

Novocure Announces National Reimbursement in Israel for Optune® in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

---

01/21/2020

Multimodal Surgical Treatment of High-Grade Gliomas in the Motor Area: The Impact of the Combination of Navigated Transcranial Magnetic Stimulation and Fluorescein-Guided Resection.

---

01/21/2020

Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

---

01/15/2020

Musella Foundation Brain Tumor Copay program is now open!

---

01/15/2020

Scientists breach brain barriers to attack tumors

---

01/13/2020

Medicenna Vaults on Brain Cancer Study

---

01/10/2020

Surgery may add months or years of survival for adults with rare and deadly brain cancers

---

01/10/2020

Optimal adjuvant therapy in elderly glioblastoma: results from a systematic review and network meta-analysis

---

01/09/2020

Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide.

---

01/08/2020

New book takes a humorous look at brain cancer

---

01/08/2020

Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma.

---

01/07/2020

DIPG Advocacy Group Announces Congressional Briefing for Pediatric Brain Cancer

---

01/06/2020

Musella Foundation Awards $250,000 Brain Tumor Research Grant

---

01/05/2020

Mount Sinai Receives More Than $10 Million in Grant Funding for Brain Tumor Research

---

01/04/2020

Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences?

---

01/04/2020

Cost-effectiveness analysis of the addition of bevacizumab to temozolomide therapy for the treatment of unresected glioblastoma.

---

01/04/2020

Complete radiological response following subtotal resection in three glioblastoma patients under treatment with Tumor Treating Fields.

---

12/28/2019

Made website more accessable! Click the logo on top right of any page to see!

---

12/25/2019

A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).

---

12/25/2019

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma.

---

12/25/2019

Safety and efficacy of VB-111, an anti-cancer gene-therapy, in patients with recurrent glioblastoma: results of a phase I/II study

---

12/16/2019

Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.

---

12/03/2019

Musella Foundation`s Annual Giving Campaign

---